INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows

  Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.

• Different Stakeholder Perspectives On Navigating DHT Guidance

  In a recent panel, industry leaders discussed the implications of FDA guidance for sponsors and developers implementing DHT as an innovative way to capture multidimensional patient data remotely.

• Advancing Patient-Centric Research With DHTs

  Sleep quality is pivotal for overall health. Explore how wearable digital health technologies can revolutionize our understanding of sleep and enhance research outcomes.

• 5 Strategies To Dramatically Improve Clinical Data Quality

  Discover how to unify data management and risk-based quality management approaches and augment processes with automation and AI to find and fix data quality issues sooner and more efficiently.

• How To Improve Patient Outcomes Using eSource Software In Clinical Trials

  8/11/2025

  As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.

• The AI Revolution In Clinical Trials

  11/13/2025

  AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.

• Empowering Transformation Through Technology

  4/24/2024

  By outlining the transformation of clinical data management into data science, this paper highlights the growing responsibility of data managers as stewards of all clinical trial data and its overall quality.

• Hidden Costs Of Data Cleaning: Build Quality At The Source

  12/11/2025

  Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.

• GSK And Medable Discuss The Next Phase Of DCTs

  3/10/2025

  GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.